Total Funding
58
80
Total FundingSeries A raised
Growth Score 58 in past quarter
-3 pts
Heat Score 80 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
74339
Ophiomics is clinical-stage Medtech company developing IVD devices (AI, genomics) for in oncology.
- Jose Pereira Leal: Founder and CEO
- Joana Cardoso Vaz: Founder, CSO and CTO
About the Company
Ophiomics is an ISO 13485 and ISO 9001 certified, clinical-stage Medtech company developing cutting-edge diagnostic products and services integrating bioinformatics, artificial intelligence and genomics in support of diagnostic, prognostic, treatment selection and clinical follow-up in oncology. It currently has a rich pipeline of products at
different development stages, from pre-clinical programs to products undergoing clinical validation.